ENDO USA, INC. EXECUTIVE EMPLOYMENT AGREEMENTRelease Agreement • July 26th, 2024 • Endo, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledJuly 26th, 2024 Company Industry JurisdictionTHIS AGREEMENT (this “Agreement”) is hereby effective as of May 10, 2024 (the “Effective Date”), by and between Endo USA, Inc. (the “Company”), a wholly-owned subsidiary of Endo, Inc. (“Endo”), and Matthew J. Maletta (“Executive”) (hereinafter collectively referred to as “the parties”).
ENDO USA, INC. EXECUTIVE EMPLOYMENT AGREEMENTRelease Agreement • July 26th, 2024 • Endo, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledJuly 26th, 2024 Company Industry JurisdictionTHIS AGREEMENT (this “Agreement”) is hereby effective as of May 10, 2024 (the “Effective Date”), by and between Endo USA, Inc. (the “Company”), a wholly-owned subsidiary of Endo, Inc. (“Endo”), and Mark Bradley (“Executive”) (hereinafter collectively referred to as “the parties”).
ENDO USA, INC. EXECUTIVE EMPLOYMENT AGREEMENTRelease Agreement • July 26th, 2024 • Endo, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledJuly 26th, 2024 Company Industry JurisdictionTHIS AGREEMENT (this “Agreement”) is hereby effective as of May 10, 2024 (the “Effective Date”), by and between Endo USA, Inc. (the “Company”), a wholly-owned subsidiary of Endo, Inc. (“Endo”), and Patrick Barry (“Executive”) (hereinafter collectively referred to as “the parties”).
ENDO USA, INC. EXECUTIVE EMPLOYMENT AGREEMENTRelease Agreement • July 26th, 2024 • Endo, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledJuly 26th, 2024 Company Industry JurisdictionTHIS AGREEMENT (this “Agreement”) is hereby effective as of May 10, 2024 (the “Effective Date”), by and between Endo USA, Inc. (the “Company”), a wholly-owned subsidiary of Endo, Inc. (“Endo”), and Blaise Coleman (“Executive”) (hereinafter collectively referred to as “the parties”).